Noteworthy effect of slight variation in aliphatic chain length of trisubstituted imidazole inhibitors against epidermal growth factor receptor L858R/T790M/C797S mutant in cancer therapy.
L858R/T790M/C797S
MD simulation
binding free energy
epidermal growth factor receptor
non-small-cell lung cancer
Journal
Chemical biology & drug design
ISSN: 1747-0285
Titre abrégé: Chem Biol Drug Des
Pays: England
ID NLM: 101262549
Informations de publication
Date de publication:
05 2019
05 2019
Historique:
received:
07
09
2018
revised:
24
11
2018
accepted:
16
12
2018
pubmed:
26
12
2018
medline:
14
2
2020
entrez:
25
12
2018
Statut:
ppublish
Résumé
11h is a very potent inhibitor against epidermal growth factor receptor triple mutation L858R/T790M/C797S (EGFR
Substances chimiques
Imidazoles
0
Protein Kinase Inhibitors
0
imidazole
7GBN705NH1
ErbB Receptors
EC 2.7.10.1
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
798-810Informations de copyright
© 2018 John Wiley & Sons A/S.